An elderly patient who was initially suspected of having antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) was instead diagnosed with multiple myeloma, according to a case report ...

The positive CHMP opinion is supported by data from the pivotal LINKER-MM1 trial, which evaluated linvoseltamab in adults with R/R MM. Earlier this month, the FDA accepted for review the Biologics ...

(NASDAQ: REGN) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending conditional marketing ...

multiple myeloma (MM). The recommendation is specific to those who have received at least three prior therapies, including a proteasome inhibitor, an immunomodulatory agent and an anti-CD38 ...

About Multiple Myeloma As the second most common blood ... and risks associated with litigation and other proceedings and government investigations relating to the Company and/or its operations ...

The list of cancers federal officials tagged for streamlined claims processes through the Labor Department’s Office of Workers’ Compensation Programs included esophageal, colorectal, prostate, ...

7, 2025 — Research into the impact of the COVID pandemic on children and young people with brain tumors has revealed how investigations or treatments were frequently postponed as key people or ...

Sep. 30, 2024 — Promising new inroads into critical DNA testing has been forecast by experts who have applied machine learning to DNA profiling. From medical diagnostics to forensic tests and ...

A similar treatment, also available on the continent, is Abecma, while there are a further four “combination therapies” for myeloma, which involve multiple drugs being taken at the same time ...